Here’s Why Regeneron Gained 11% Last Month
What happened
Biopharma name Regeneron Pharmaceuticals (NASDAQ:REGN) rallied 11.2% in June, according to data from S&P Global Market Intelligence. A series of encouraging drug-development updates kept the recovery rally going.
So what
A multi-month pullback…
